Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventing Cross-Contamination: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 17, 2013
May 14, 2020
8f4551af-85d4-4a2c-9a05-f4a01a143967
Related Documents
Abuse-Deterrent Opioids-Evaluation and Labeling
Guidance DocumentApril 2, 2015Center for Drug Evaluation and Research
Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs
Guidance DocumentDecember 3, 2012Center for Drug Evaluation and Research
Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography
Guidance DocumentApril 11, 2012Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox